SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The filing discloses a press release announcing financial results for Take-Two's fourth fiscal quarter and full fiscal year ended March 31, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →Julie M. Pelkowski, Executive Vice President and Chief Financial Officer, is retiring at the end of 2026 after more than 25 years with the Company. The departure of a principal financial officer is material to investors as it affects the registrant's financial leadership and disclosure controls. The filing explicitly discloses this as a departure with no disagreement or dispute.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from CuriosityStream's May 20, 2026 annual meeting under Item 5.07. The filing reports detailed vote tallies for five proposals: director elections (three Class III directors elected), rejection of a plan increase amendment, ratification of Grant Thornton LLP as auditor, advisory approval of executive compensation, and a one-year frequency recommendation for future compensation votes. The material outcomes include the failure of the Plan Increase Proposal and the approval of all other matters, which are substantive governance decisions affecting investors' understanding of board composition and capital allocation authority.
View raw filing on EDGAR →Steven M. Yi did not stand for re-election as a director and completed his tenure on May 21, 2026, resulting in his departure from the Board of Directors.
View raw filing on EDGAR →White Mountains Insurance Group held its 2026 Annual General Meeting on May 21, 2026, with shareholders voting on three proposals: election of four Class II directors, advisory approval of executive compensation, and appointment of PricewaterhouseCoopers LLP as independent auditor.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Harte Hanks' 2026 Annual Meeting of Stockholders held on May 21, 2026. The filing presents voting tallies for three matters: election of four board nominees (Genni Combes, John H. Griffin Jr., Bradley Radoff, and Elizabeth Ross), advisory approval of named executive officer compensation, and ratification of Wolf & Company P.C. as independent auditor. This is a quintessential Item 5.07 disclosure and is material to investors as it documents the outcomes of fundamental corporate governance votes.
View raw filing on EDGAR →Peggy S. Rebstock was appointed by the Board on May 20, 2026, to serve as Vice President, Chief Accounting Officer and Controller, effective May 21, 2026, with a base salary of $320,000, 50% target cash incentive, and equity awards.
View raw filing on EDGAR →Knife River Corp held its annual stockholder meeting on May 20, 2026, with shareholders voting on three proposals: election of two Class III directors (Karen B. Fagg and Brian R. Gray), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. All three proposals passed.
View raw filing on EDGAR →This Item 7.01 disclosure presents portfolio commentary and performance metrics for TCAP as of March 31, 2026, including year-to-date and trailing twelve-month returns (2.5% and 10.3% respectively), portfolio composition statistics, and market analysis. While the disclosure contains material performance information relevant to investors in the fund, it does not fit neatly into the specific event categories (e.g., it is not an earnings release with formal financial statements, nor does it announce a specific corporate action like M&A, executive changes, or covenant breaches). The commentary is primarily informational and forward-looking rather than announcing a discrete material event, making "other_material" the most appropriate classification for this portfolio update disclosure.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Northrop Grumman's 2026 Annual Meeting of Shareholders held on May 20, 2026. The filing presents final certified voting tallies for four proposals: election of eleven directors, advisory approval of named executive officer compensation, ratification of Deloitte & Touche LLP as independent auditor, and a shareholder proposal on independent board chair. This is a material event as it reflects shareholder approval of key governance and compensation matters.
View raw filing on EDGAR →The filing discloses a press release announcing clinical trial results for Bicara's lead candidate ficerafusp alfa plus pembrolizumab, demonstrating three-year overall survival and deep responses in HPV-negative HNSCC. While this is a clinical data announcement rather than financial earnings, it represents material clinical progress that would significantly affect investor assessment of the company's pipeline and commercial prospects. The press release is attached as Exhibit 99.1 and incorporated by reference, consistent with how material clinical milestones are disclosed under Item 8.01.
View raw filing on EDGAR →Mr. Josh Smiley's departure as President and Chief Operating Officer, effective May 18, 2026, with final employment termination on May 22, 2026, is the principal disclosed action. The filing centers on his cessation of service and severance arrangement, making this a clear executive departure. The assumption of his responsibilities by the CEO and management team is secondary to the departure itself.
View raw filing on EDGAR →Diego Scotti departed as EVP, General Manager, Consumer Group effective June 2, 2026. The filing discloses his separation agreement and severance eligibility under the company's equity plan.
View raw filing on EDGAR →PayPal held its Annual Meeting of Stockholders with voting results on six proposals: election of 11 directors (96.6%–99.3% approval), advisory approval of named executive officer compensation (90.2%), approval of the 2026 Equity Incentive Award Plan (72.5%), ratification of PricewaterhouseCoopers LLP as auditor (91.2%), and rejection of two stockholder proposals on conflict zones policy and special meeting thresholds.
View raw filing on EDGAR →The filing discloses the appointment of Alfred T. Rogers, Jr. as President, Chief Executive Officer, and Board member of BayFirst Financial Corp., effective May 14, 2026, following Federal Reserve approval. This is a principal executive officer appointment at a financial institution, which is material to investors assessing company leadership and governance.
View raw filing on EDGAR →This Item 2.03 disclosure describes the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of New York. While the filing explicitly states "consolidated obligations issuance is material to the Bank," the disclosure is primarily informational and regulatory in nature—explaining the structure, joint-and-several liability framework, and reporting methodology for consolidated obligations rather than announcing a specific new debt issuance event. The absence of a Schedule A with specific issuance details in the provided text, combined with the general explanatory tone, suggests this may be a routine periodic disclosure rather than a discrete material event triggering Item 2.03. Classified as other_material because the disclosure addresses material financial obligations but does not fit cleanly into covenant_breach or other specific event categories.
View raw filing on EDGAR →The filing discloses a dividend declaration by the FHLBNY Board of Directors for Q1 2026, announced via a President's Report to members. While dividend declarations are material to shareholders/members, this does not fit the earnings_release category (which typically involves comprehensive financial results) nor any other specific event type. The disclosure is material to members' assessment of the institution's capital distribution policy and financial health, warranting classification as other_material.
View raw filing on EDGAR →This Item 5.07 filing discloses the final voting results from Beyond Meat's 2026 Annual Meeting of Stockholders held on May 20, 2026, covering three proposals: election of Class I directors (Proposal 1), ratification of Deloitte & Touche LLP as independent auditor (Proposal 2), and an advisory vote on named executive officer compensation (Proposal 3). The disclosure includes detailed vote tallies for each proposal, making this a clear shareholder_vote_results event. The failure to approve executive compensation (Proposal 3) on an advisory basis is material to investors assessing management and governance.
View raw filing on EDGAR →The FDA reclassified Bioventus's Exogen bone growth stimulator from Class III to Class II, triggering CMS updates to Medicare reimbursement rates effective May 18, 2026. While the company states it does not presently expect a material impact on 2026 results and is reiterating guidance, the disclosure acknowledges potential long-term impacts and notes that "further changes by CMS...could require the Company to revise its financial outlook." This regulatory change affecting a core product's reimbursement is material to investors, though it does not fit neatly into the more specific event categories (not a restatement, impairment, or covenant breach, but a significant regulatory development with acknowledged future financial uncertainty).
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Kinsale Capital Group's 2026 annual meeting held on May 21, 2026, covering three proposals: election of nine directors, advisory vote on named executive officer compensation, and ratification of KPMG LLP as independent auditor. The filing presents vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the standard format for Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →The disclosure announces release of interim Phase 2 clinical trial data for FID-007 in combination with cetuximab for head and neck squamous cell carcinoma. While clinical trial results can be material to biotech/pharma investors, this filing lacks specificity about the trial outcomes, efficacy metrics, or clinical significance—it merely announces that an abstract was "released" without disclosing the actual results. This appears to be a clinical milestone announcement rather than a traditional earnings release or material event with clear financial/operational impact, warranting classification as other_material.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from FVCBankcorp's Annual Meeting of Shareholders held on May 20, 2026, covering three proposals: election of 12 directors, approval of named executive officer compensation, and ratification of the independent auditor (Yount, Hyde & Barbour, P.C.). The filing presents detailed voting tallies for each matter, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →The filing discloses a "contemplated sale of the Transit Business" announced via press release on May 21, 2026. This is a material disposition or divestiture activity that would affect investor assessment of the company's asset base and strategic direction. Although disclosed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 1.02 or 2.01, the substance is clearly a material M&A event — the planned sale of a business segment.
View raw filing on EDGAR →Z Squared Inc. announced a Phase 1 plan to reach 100 MW of AI-ready infrastructure capacity for inference workloads via press release on May 19, 2026. This disclosure under Item 7.01 (Regulation FD Disclosure) represents a material business development or strategic initiative that would affect a reasonable investor's assessment of the company's growth trajectory and capital deployment plans, but does not fit neatly into the more specific event categories (not an earnings release, M&A activity, executive change, or financial restatement). The announcement of significant infrastructure expansion capacity is material to investors evaluating the company's operational strategy and competitive positioning.
View raw filing on EDGAR →Nocera entered into an unregistered sale of equity securities as part of a Strategic Advisory Agreement with Phoenix MGMT & Consulting LLC, involving an initial $150,000 retainer, $50,000 monthly fees, quarterly equity grants, and transaction-based fees of 5% of M&A value.
View raw filing on EDGAR →Chilean Cobalt Corp. entered into a material definitive agreement disclosed under Item 1.01, but the filing text is incomplete and cuts off mid-sentence, making it impossible to determine the specific nature of the agreement or whether it constitutes an acquisition, disposition, merger, or other material transaction.
View raw filing on EDGAR →Chilean Cobalt Corp. completed an unregistered private placement sale of 1,562,500 shares of common stock at $1.60 per share for $2.5 million in aggregate proceeds to existing investors Glencore and Madesal under Section 4(a)(2) and Regulation D Rule 506, with proceeds designated for exploration and corporate purposes.
View raw filing on EDGAR →The Company disclosed via press release that it failed to file its Form 10-Q for Q1 2026 by the extended deadline of May 20, 2026. This is a material disclosure of non-compliance with SEC filing requirements that would affect investor assessment of the registrant's operational and regulatory standing. While this could signal delisting risk or other underlying issues, the disclosure itself centers on the filing delinquency rather than a specific delisting notice or going-concern statement.
View raw filing on EDGAR →SEACOR Marine entered into a Letter Agreement modifying its 2024 Credit Agreement, releasing $13.7 million from escrow to fund PSV construction and canceling $24.6 million in undrawn Tranche B commitments. This restructuring materially affects the company's capital structure and financing arrangements for the acquisition of two $41 million PSVs.
View raw filing on EDGAR →SEACOR Marine completed the sale of five vessels (two PSVs, one FSV, and two liftboats) for $46.5 million in gross proceeds, reducing its fleet from 43 to 38 vessels. This material disposition of assets represents a significant change to the company's asset base and liquidity position.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from Ecovyst Inc.'s 2026 Annual Meeting of Stockholders held on May 20, 2026. The filing reports final voting tallies for three proposals: election of five Class I directors, advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All proposals passed with substantial majorities, making this a material governance event that investors rely upon to assess board composition and executive accountability.
View raw filing on EDGAR →Liberty Latin America announced and issued Series A Preference Shares (9.0% Fixed Rate Cumulative Perpetual Redeemable) distributed as a special dividend at a 1-for-10 ratio to common shareholders. The new preferred shares carry material economic terms including fixed dividend accrual, liquidation preferences, optional redemption rights, and conditional director election rights triggered by dividend non-payment, materially affecting the company's capital structure and future cash obligations.
View raw filing on EDGAR →Zentalis announced Phase 1b clinical trial data for azenosertib in combination with paclitaxel in platinum-resistant ovarian cancer patients, demonstrating an ORR of 39.1% and median PFS of 7.3 months with a manageable safety profile. This represents a significant clinical milestone for the company's lead drug candidate.
View raw filing on EDGAR →VisionWave issued 475,492 newly issued shares of common stock to T3 Defense Inc. in a private placement exempt from registration under Section 4(a)(2) of the Securities Act. The shares were issued as restricted securities with a customary restrictive legend and contractual transfer restrictions. This is a dilutive equity issuance that would materially affect existing shareholders' ownership percentages and is a key indicator of capital-raising activity at a small-cap issuer.
View raw filing on EDGAR →Monroe Capital Income Plus Corp conducted an unregistered private placement of 1,174,995 shares of common stock at $9.77 per share, raising approximately $11.48 million in aggregate proceeds pursuant to subscription agreements and exempt under Section 4(a)(2) and Regulation D/S.
View raw filing on EDGAR →The board declared a dividend distribution of $0.071 per share, with the net asset value per share as of April 30, 2026 reported at $9.77.
View raw filing on EDGAR →Hovnanian Enterprises issued a press release on May 21, 2026 announcing preliminary financial results for the fiscal second quarter ended April 30, 2026, attached as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, providing quarterly financial results and non-GAAP reconciliations that would materially affect investor assessment of the company's operating performance.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Envista's May 19, 2026 Annual Meeting of Stockholders. The filing reports the outcomes of four proposals: election of eight directors, ratification of Ernst & Young LLP as independent auditor, advisory approval of executive compensation, and frequency of future advisory votes on compensation. The detailed vote tallies (votes for, against, abstained, and broker non-votes) for each proposal are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →Kontoor Brands entered into a Stock Purchase Agreement to sell its wholly-owned subsidiary The H.D. Lee Company to ABG-Storm LLC (an Authentic Brands Group affiliate) for $750 million in cash plus up to $250 million in earnout consideration. The transaction has been unanimously approved by the Board and is expected to close in H2 2026, with proceeds earmarked for debt reduction and shareholder returns.
View raw filing on EDGAR →Carvana Receivables Depositor LLC and Carvana, LLC entered into an underwriting agreement for the issuance of approximately $1.1 billion in asset-backed notes through a securitization trust, involving the transfer of motor vehicle retail installment sales contracts as collateral.
View raw filing on EDGAR →This filing discloses the public issuance of multiple classes of Asset Backed Notes (Class A-1 through Class D) by Carvana Auto Receivables Trust 2026-P2, with the Registrant filing to satisfy an undertaking to provide legality and tax opinions. While the issuance itself is a material financing event, it does not fit neatly into the more specific categories (not a traditional M&A activity, not a dilutive equity issuance, not a restatement or going-concern disclosure). The materiality stems from the significant debt issuance and the formal legal opinions required to support it.
View raw filing on EDGAR →Perella Weinberg Partners issued 1,908,084 shares of Class A common stock on May 18, 2026, in exchange for partnership units and Class B shares held by limited partners. The transaction was structured as an unregistered exchange under Section 4(a)(2) of the Securities Act, involving a material issuance of equity securities that dilutes existing shareholders. This is a classic dilutive issuance disclosure under Item 3.02.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from First Watch Restaurant Group's Annual Meeting of Stockholders held on May 20, 2026. The filing reports final voting tallies for four proposals: election of Class II directors (Irene Chang Britt, Charles Jemley, Rachel Tipograph), advisory approval of named executive officer compensation, advisory frequency vote on future compensation votes (approved for annual frequency), and ratification of PricewaterhouseCoopers LLP as independent auditor. The detailed vote counts for each proposal are provided in tabular form, which is the standard format for shareholder vote result disclosures.
View raw filing on EDGAR →Blackstone Private Credit Fund completed an unregistered private placement of 2,171,851 Class I common shares for $52.3 million, conducted pursuant to Section 4(a)(2) and Regulation S exemptions.
View raw filing on EDGAR →The Fund disclosed its NAV per share of $24.06 as of April 30, 2026, aggregate NAV of $45.2 billion, portfolio fair value of $79.0 billion, debt outstanding of $37.1 billion, and ongoing public and private offerings totaling $56.8 billion in consideration, reflecting the Fund's substantial size and leverage metrics.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Pattern Group Inc.'s Annual Meeting of Stockholders held on May 15, 2026. The filing presents voting outcomes for four proposals: election of directors (Scott Hilton and Ann Mather), ratification of Deloitte & Touche LLP as independent auditor, Say on Pay advisory vote, and Say on Frequency vote. All proposals passed with substantial majorities, making this a material shareholder vote results disclosure.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from Rocket Lab's 2026 Annual Meeting of Stockholders held on May 20, 2026. The filing presents voting tallies for four proposals: election of a Class II director (Edward H. Frank), ratification of Deloitte & Touche LLP as auditor, advisory approval of named executive officer compensation, and approval of a subsidiary merger to eliminate a pass-through voting provision. The detailed vote counts (for, against, abstain, broker non-votes) are the hallmark of shareholder_vote_results disclosures.
View raw filing on EDGAR →Picard Medical disclosed financial results for Q1 2026 (ended March 31, 2026) via a press release dated May 21, 2026, furnished as Exhibit 99.1.
View raw filing on EDGAR →The Company received a written notice from NYSE American on May 15, 2026, indicating non-compliance with continued listing standards due to a stockholders' deficit of approximately $1.4 million (against a required minimum of $2.0 million) and losses in three consecutive fiscal years. The Company must submit a compliance plan by June 7, 2026, or face delisting procedures by November 8, 2027.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Catalyst Bancorp's Annual Meeting of Shareholders held on May 19, 2026. The filing reports voting outcomes for two proposals: (1) election of directors Frederick R. Lafleur and Matthew L. Scruggins for three-year terms, and (2) ratification of BDO USA, P.C. as independent auditor. Both proposals passed. This is a routine but material Item 5.07 disclosure required by SEC rules.
View raw filing on EDGAR →